Shehnaaz Suliman, Director at 10x Genomics, Inc. (TXG), sold 5,723 shares at $78.20 ($465K) on 2026-09-22, disclosed to the SEC on 2026-09-24.
Scheduled sale ($465k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.20 | 292 | $23K | 4.9% |
| 2 | $79.51 | 614 | $49K | 10.5% |
| 3 | $80.82 | 1,325 | $107K | 23.0% |
| 4 | $81.67 | 2,270 | $185K | 39.9% |
| 5 | $82.28 | 1,222 | $101K | 21.6% |
| Total | $81.19 avg | 5,723 |
| $465K |
| 100% |
| Filing → |
| RARE | SELL | 2026-05-18 | $144K | — | Filing → |
| ALEC | SELL | 2021-12-14 | $6.5M | — | Filing → |
| ALEC | SELL | 2021-12-10 | $6.8M | — | Filing → |